Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/1758-5899.12876 http://scihub22266oqcxt.onion/10.1111/1758-5899.12876 33230401!7675476!33230401     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Glob+Policy 2020 ; 11 (5): 647-649 Nephropedia Template TP {{tp|p=33230401|t=2020. Inclusive Biomedical Innovation during the COVID-19 Pandemic |pdf=|usr=}}{{33230401}} gab.com Text Inclusive Biomedical Innovation during the COVID-19 Pandemic JO: Glob Policy http://www.kidney.de/pget.php?&tw=1&pmid=33230401 #FOAvip CEPI represents the first step towards Joseph Stiglitz's vision, cited by Gubby, of a fund which provides large rewards for cures to common diseases such as malaria, and smaller rewards for rarer diseases or less innovative 'me-too' drugs (Stiglitz, BMJ, 333, 2006, pp. 1279-1280). As a fledgling organization facing a Goliath, it deserves international support in its dual goals of incentivizing innovation and ensuring equitable access to biomedical advances. Twit Text FOAVip Inclusive Biomedical Innovation during the COVID-19 Pandemic ????Glob Policy http://www.kidney.de/pget.php?&tw=1&pmid=33230401 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33230401 #FOAvip English Wikipedia <ref>{{Cite pmid|33230401}}</ref> Inclusive Biomedical Innovation during the COVID-19 Pandemic #MMPMID33230401 Pannu J Glob Policy 2020[Nov]; 11 (5): 647-649 PMID33230401show ga CEPI represents the first step towards Joseph Stiglitz's vision, cited by Gubby, of a fund which provides large rewards for cures to common diseases such as malaria, and smaller rewards for rarer diseases or less innovative 'me-too' drugs (Stiglitz, BMJ, 333, 2006, pp. 1279-1280). As a fledgling organization facing a Goliath, it deserves international support in its dual goals of incentivizing innovation and ensuring equitable access to biomedical advances. äInclusive Biomedical Innovation during the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing